探索身体质量指数和喘之间的机制和关系:孟德尔随机化结果的发现
Yanjiang Yang1, Xiaorui Wang2, Wenwen Yang3
1Department of Rheumatology and Immunology, The People's Hospital of Qiandongnan Autonomous Prefecture, Kaili, Guizhou Province, China.
概括
肥胖通过各种血液生物标志物增加了喘风险. 13个关键生物标志物,包括白细胞计数和阿波利波蛋白A,调解了这种联系,解释了50%以上的风险. 需要进一步的研究.
科学领域:
- 遗传学和流行病学
- 生物标志物发现发现
- 呼吸系统医学 呼吸系统医学
背景情况:
- 身体质量指数 (BMI) 和喘之间的病因联系尚不清楚.
- 肥胖是喘的已知危险因素,但潜在的机制需要阐明.
研究的目的:
- 为了研究BMI和喘之间的因果关系.
- 确定特定的血液生物标志物,这些生物标志物调解了BMI和喘风险之间的关联.
主要方法:
- 使用汇总级GWAS数据进行门德尔随机化 (MR) 分析.
- 采用了反变差加权 (IVW),加权中位数 (WM) 和MR-Egger方法.
- 进行了两步调解分析,以评估因果途径.
主要成果:
- 体重指数升高与喘风险增加有显著的相关性.
- 确定了13种生物标志物,包括白细胞计数,阿波利波蛋白A,囊素C,尿酸盐,透静血压和白蛋白,作为显著的调解剂.
- 这些调解者共同占BMI相关喘风险的50%以上.
结论:
- 肥胖,血液生物标志物和喘之间的关系是复杂的.
- 确定了关键的调解生物标志物,为肥胖-喘途径提供了洞察力.
- 需要在不同人群中进行进一步的验证,以确认因果关系.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
374
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
374
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
251
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
251


